X

Trial Profile

A Double-blind, Randomized, Parallel-group, Placebo-controlled Study of MLE4901 for the Treatment of Polycystic Ovary Syndrome (PCOS)

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 06 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pavinetant (Primary)
Indications Polycystic ovary syndrome
Focus Therapeutic Use
Sponsors Millendo Therapeutics

Most Recent Events

28 Sep 2017 Status changed from active, no longer recruiting to discontinued as the risk/benefit profile no longer indicated continued development.
21 Jun 2017 Status changed from recruiting to active, no longer recruiting.
04 Apr 2017 Trial design presented at The 99th Annual Meeting of the Endocrine Society

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com